Product analysis
LFG Burn Berry offers caffeine-based alertness and exercise support, with beta-alanine more relevant to repeated use over several weeks. The extra focus ingredients have less certain benefits for healthy adults.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality32
Caffeine and several other ingredients have named forms, but their absorption advantages remain uncertain. Beta-alanine, alpha-GPC and huperzine have less complete form disclosure, limiting comparisons.
Ingredient Transparency71
Ingredient amounts and most forms are disclosed, making much of the serving understandable. The proprietary blend contents and the split between combined forms remain unclear.
Value For Money35
The serving is relatively costly when judged by its caffeine contribution, while huperzine offers moderate value by amount. Uncertain value for the remaining ingredients makes the premium harder to assess.
Customer Satisfaction74
Customer feedback is very positive, but only a small number of people have rated it. A wider range of experiences would make the picture more dependable.
Product Focus34
Alertness and exercise support are the clearest uses, largely through caffeine and beta-alanine. The caffeine serving may cause jitteriness or anxiety, while the broader brain and metabolism uses have more limited support.
- Format
Powder - Container
- 10 Ounce(s)
- Per serving
- $1.68
- Customer rating
- 4.9 · 18 ratings
Goals
No linked studies yet.
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Sodium (Himalayan Rock Salt, Sodium Citrate) | 80 mg | |
Beta-Alanine | 3200 mg | |
Nitrosigine (Inositol-Stabilized Arginine Silicate) | 1500 mg | |
Caffeine (Caffeine Anhydrous, Caffeine Anhydrous, Microencapsulated) | 300 mg | |
MitoBurn (Beta-Aminoisobutyric Acid) | 250 mg | |
AlphaSize Alpha GPC | 200 mg | |
Mucuna pruriens extract (L-Dopa) | 100 mg | |
AstraGin (Astragalus membranaceous, Panax notoginseng) | 25 mg | |
Paradoxine (Grains of Paradise) | 10 mg | |
Huperzine A | 200 mcg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability20
Source and Standardization Clarity
Dose, Safety & Label Transparency88
Huperzine A Dosage Efficacy
Cycling Guidance and Transparency
Value50
Price per 100mcg of Huperzine A
How this ingredient is rated
Active Ingredient Quality & Bioavailability40
Advanced Bioavailability and Release Profiles
Dose, Safety & Label Transparency92
Caffeine Dose Transparency
Dosage Efficacy and Safety Margin
Secondary Stimulant Disclosure and Risk
Value10
Price Per Serving vs. Collection Median
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Patented/Branded Form and Source
Dose, Safety & Label Transparency38
Active Alpha-GPC Dosage
Label Transparency & Yield Disclosure
Value10
Price per 300mg Active Alpha-GPC
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
- Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
- [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
- Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
- Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
- [Drug evaluation of huperzine A in the treatment of senile memory disorders].
- Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine.
- Caffeine-containing energy drink improves physical performance of elite rugby players during a simulated match.
- Differential cognitive effects of energy drink ingredients: caffeine, taurine, and glucose.
- Does Single or Combined Caffeine and Taurine Supplementation Improve Athletic and Cognitive Performance without Affecting Fatigue Level in Elite Boxers? A Double-Blind, Placebo-Controlled Study.
- Trait Energy and Fatigue Modify the Effects of Caffeine on Mood, Cognitive and Fine-Motor Task Performance: A Post-Hoc Study.
- The effect of L-arginine supplementation on maximal oxygen uptake: A systematic review and meta-analysis.